Andrea Visentin

68PUBLICATIONS
247CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursNeurology and neuromuscular diseasesCardiovascular medicine and haematology not elsewhere classifiedNaturopathy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (68)

|Aug 27, 2026
Radiation-Free Therapy for the Initial Treatment of Good Prognosis Early Non-Bulky Hodgkin Lymphoma, Defined by a Low Metabolic Tumor Volume and a Negative Interim PET After 2 Chemotherapy Cycles: The RAFTING Trial Protocol.

|Aug 19, 2026
Minimal residual disease-guided ibrutinib and venetoclax in patients with chronic lymphocytic leukaemia and complex karyotype.

|Feb 24, 2026
Chronic Ataxic Neuropathy With Disialosyl Antibodies Responsive to Zanubrutinib.

Benedetta Tierro, Andrea Visentin, Alessandro Salvalaggio

|Feb 18, 2026
Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformation.

Chiara Cosentino, Samir Mouhssine, Antonella Zucchetto

|Jan 24, 2026
Pachymeningeal Involvement in POEMS Syndrome: Longitudinal Follow-Up Study and Correlation With Therapeutic Response.

Chiara Briani, Luca Massarotti, Antonio Branca

|Jan 07, 2026
Real-world safety and effectiveness of zanubrutinib vs ibrutinib in CLL: the CLL-ZANU2024 Italian cohort.

Enrica Antonia Martino, Annalisa Pitino, Ernesto Vigna

Pageof 12

Frequent Collaborators

33 joint publications

Livio Trentin

16 joint publications

Luca Laurenti

13 joint publications

Francesca Romana Mauro

12 joint publications

Federica Frezzato